Useful Photoprotection in Dermatological Practice

Disclosure: Prof Trautinger has acted as consultant/advisor to AbbVie, Angelini, BMS, Eli Lilly, Galderma, Leo, MSD, Novartis, Roche, and Sanofi; received speaker’s honoraria from BMS, Galderma, Hollister, Leo, MSD, Novartis, and Roche; and received research grants from AbbVie, Angelini, and Roche. Prof Passeron has been an advisor/consultant for AbbVie, Galderma, ISIS Pharma, Janssen, La Roche-Posay, Lancôme, Novartis, Pfizer, SVR, and Symrise; was a speaker for Abbvie, Beiersdorf, Bioderma, Galderma, GSK, ISIS Pharma, Janssen, La Roche-Posay, Lancôme, Leo Pharma, MSD, Novartis, Pfizer, SVR, Syneron, and Vichy; and received clinical research grant from Beiersdorf, Bioderma, DELEO, Galderma, Lancôme, MSD, and Syneron. Dr Moyal is a full-time employee of La Roche-Posay Dermatological Laboratories (Asnières, France). Acknowledgements: Writing assistance was provided by Mia Cahill of ApotheCom, London, UK. Support: The publication of this article was funded by La Roche-Posay for presentation at the European Academy of Dermatology and Venereology Congress 2016. The views and opinions expressed are those of the authors and not necessarily La Roche-Posay or the European Academy of Dermatology and Venereology. Citation: EMJ Dermatol. 2016;4[1]:32-38.